StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
RBC Capital on Boston Scientific (BSX): 'Results Point to Positive Uptake'
March 30, 2026 8:56 AM
RBC Capital analyst Shagun Singh reiterated an Outperform rating and $115.00 price target on Boston Scientific (NYSE: BSX).The analyst commented ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
